These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 30987997)

  • 1. Cholesterol Induces Epithelial-to-Mesenchymal Transition of Prostate Cancer Cells by Suppressing Degradation of EGFR through APMAP.
    Jiang S; Wang X; Song D; Liu X; Gu Y; Xu Z; Wang X; Zhang X; Ye Q; Tong Z; Yan B; Yu J; Chen Y; Sun M; Wang Y; Gao S
    Cancer Res; 2019 Jun; 79(12):3063-3075. PubMed ID: 30987997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CKB inhibits epithelial-mesenchymal transition and prostate cancer progression by sequestering and inhibiting AKT activation.
    Wang Z; Hulsurkar M; Zhuo L; Xu J; Yang H; Naderinezhad S; Wang L; Zhang G; Ai N; Li L; Chang JT; Zhang S; Fazli L; Creighton CJ; Bai F; Ittmann MM; Gleave ME; Li W
    Neoplasia; 2021 Nov; 23(11):1147-1165. PubMed ID: 34706306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IFNγ-Induced IFIT5 Promotes Epithelial-to-Mesenchymal Transition in Prostate Cancer via miRNA Processing.
    Lo UG; Pong RC; Yang D; Gandee L; Hernandez E; Dang A; Lin CJ; Santoyo J; Ma S; Sonavane R; Huang J; Tseng SF; Moro L; Arbini AA; Kapur P; Raj GV; He D; Lai CH; Lin H; Hsieh JT
    Cancer Res; 2019 Mar; 79(6):1098-1112. PubMed ID: 30504123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HER2/EGFR-AKT Signaling Switches TGFβ from Inhibiting Cell Proliferation to Promoting Cell Migration in Breast Cancer.
    Huang F; Shi Q; Li Y; Xu L; Xu C; Chen F; Wang H; Liao H; Chang Z; Liu F; Zhang XH; Feng XH; Han JJ; Luo S; Chen YG
    Cancer Res; 2018 Nov; 78(21):6073-6085. PubMed ID: 30171053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 27-Hydroxycholesterol Impairs Plasma Membrane Lipid Raft Signaling as Evidenced by Inhibition of IL6-JAK-STAT3 Signaling in Prostate Cancer Cells.
    Dambal S; Alfaqih M; Sanders S; Maravilla E; Ramirez-Torres A; Galvan GC; Reis-Sobreiro M; Rotinen M; Driver LM; Behrove MS; Talisman TJ; Yoon J; You S; Turkson J; Chi JT; Freeman MR; Macias E; Freedland SJ
    Mol Cancer Res; 2020 May; 18(5):671-684. PubMed ID: 32019810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-644a Disrupts Oncogenic Transformation and Warburg Effect by Direct Modulation of Multiple Genes of Tumor-Promoting Pathways.
    Ebron JS; Shankar E; Singh J; Sikand K; Weyman CM; Gupta S; Lindner DJ; Liu X; Campbell MJ; Shukla GC
    Cancer Res; 2019 Apr; 79(8):1844-1856. PubMed ID: 30808676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. P21 activated kinase-1 mediates transforming growth factor β1-induced prostate cancer cell epithelial to mesenchymal transition.
    Al-Azayzih A; Gao F; Somanath PR
    Biochim Biophys Acta; 2015 May; 1853(5):1229-39. PubMed ID: 25746720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methylation decreases the Bin1 tumor suppressor in ESCC and restoration by decitabine inhibits the epithelial mesenchymal transition.
    Wang X; Wang J; Jia Y; Wang Y; Han X; Duan Y; Lv W; Ma M; Liu L
    Oncotarget; 2017 Mar; 8(12):19661-19673. PubMed ID: 28152502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Valproic acid (VPA) inhibits the epithelial-mesenchymal transition in prostate carcinoma via the dual suppression of SMAD4.
    Lan X; Lu G; Yuan C; Mao S; Jiang W; Chen Y; Jin X; Xia Q
    J Cancer Res Clin Oncol; 2016 Jan; 142(1):177-85. PubMed ID: 26206483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Berberine inhibits the metastatic ability of prostate cancer cells by suppressing epithelial-to-mesenchymal transition (EMT)-associated genes with predictive and prognostic relevance.
    Liu CH; Tang WC; Sia P; Huang CC; Yang PM; Wu MH; Lai IL; Lee KH
    Int J Med Sci; 2015; 12(1):63-71. PubMed ID: 25552920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptional Repression of SIRT3 Potentiates Mitochondrial Aconitase Activation to Drive Aggressive Prostate Cancer to the Bone.
    Sawant Dessai A; Dominguez MP; Chen UI; Hasper J; Prechtl C; Yu C; Katsuta E; Dai T; Zhu B; Jung SY; Putluri N; Takabe K; Zhang XH; O'Malley BW; Dasgupta S
    Cancer Res; 2021 Jan; 81(1):50-63. PubMed ID: 33115805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Up-regulation of TIF1γ by valproic acid inhibits the epithelial mesenchymal transition in prostate carcinoma through TGF-β/Smad signaling pathway.
    Qi G; Lu G; Yu J; Zhao Y; Wang C; Zhang H; Xia Q
    Eur J Pharmacol; 2019 Oct; 860():172551. PubMed ID: 31323225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of Akt1-β-catenin pathway in advanced prostate cancer promotes TGFβ1-mediated epithelial to mesenchymal transition and metastasis.
    Gao F; Alwhaibi A; Sabbineni H; Verma A; Eldahshan W; Somanath PR
    Cancer Lett; 2017 Aug; 402():177-189. PubMed ID: 28602980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CXADR-Mediated Formation of an AKT Inhibitory Signalosome at Tight Junctions Controls Epithelial-Mesenchymal Plasticity in Breast Cancer.
    Nilchian A; Johansson J; Ghalali A; Asanin ST; Santiago A; Rosencrantz O; Sollerbrant K; Vincent CT; Sund M; Stenius U; Fuxe J
    Cancer Res; 2019 Jan; 79(1):47-60. PubMed ID: 30385615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting the SPOCK1-snail/slug axis-mediated epithelial-to-mesenchymal transition by apigenin contributes to repression of prostate cancer metastasis.
    Chien MH; Lin YW; Wen YC; Yang YC; Hsiao M; Chang JL; Huang HC; Lee WJ
    J Exp Clin Cancer Res; 2019 Jun; 38(1):246. PubMed ID: 31182131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EGFR-mediated Rad51 expression potentiates intrinsic resistance in prostate cancer via EMT and DNA repair pathways.
    Rajput M; Singh R; Singh N; Singh RP
    Life Sci; 2021 Dec; 286():120031. PubMed ID: 34627777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. APMAP Promotes Epithelial-Mesenchymal Transition and Metastasis of Cervical Cancer Cells by Activating the Wnt/β-catenin Pathway.
    Zhu X; Xiang Z; Zou L; Chen X; Peng X; Xu D
    J Cancer; 2021; 12(20):6265-6273. PubMed ID: 34539899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulation of long non-coding RNA PlncRNA-1 promotes proliferation and induces epithelial-mesenchymal transition in prostate cancer.
    Jin Y; Cui Z; Li X; Jin X; Peng J
    Oncotarget; 2017 Apr; 8(16):26090-26099. PubMed ID: 28212533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isorhapontigenin induced cell growth inhibition and apoptosis by targeting EGFR-related pathways in prostate cancer.
    Zhu C; Zhu Q; Wu Z; Yin Y; Kang D; Lu S; Liu P
    J Cell Physiol; 2018 Feb; 233(2):1104-1119. PubMed ID: 28422286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CX3CL1 increases invasiveness and metastasis by promoting epithelial-to-mesenchymal transition through the TACE/TGF-α/EGFR pathway in hypoxic androgen-independent prostate cancer cells.
    Tang J; Xiao L; Cui R; Li D; Zheng X; Zhu L; Sun H; Pan Y; Du Y; Yu X
    Oncol Rep; 2016 Feb; 35(2):1153-62. PubMed ID: 26718770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.